|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-10-26
|
|
pubmed:abstractText |
CAMPATH-1H is a human immunoglobulin G1 (IgG1) anti-CD52 monoclonal antibody (MAb) that binds to nearly all B-cell and T-cell lymphomas. We report here the results of a multicenter phase II trial of CAMPATH-1H in patients with advanced, low-grade non-Hodgkin's lymphoma (NHL) who were previously treated with chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BrittingerGG,
pubmed-author:CrowtherDD,
pubmed-author:DombretHH,
pubmed-author:EngertAA,
pubmed-author:EpenetosAA,
pubmed-author:GisselbrechtCC,
pubmed-author:HuhnDD,
pubmed-author:JaegerUU,
pubmed-author:LundinJJ,
pubmed-author:MarcusRR,
pubmed-author:MellstedtHH,
pubmed-author:NisselHH,
pubmed-author:OsterborgAA,
pubmed-author:PoyntonCC,
pubmed-author:RankinEE,
pubmed-author:StahelRR,
pubmed-author:ThomasJJ,
pubmed-author:UppenkampMM,
pubmed-author:WillemzeRR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3257-63
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9779699-Adult,
pubmed-meshheading:9779699-Antibodies, Monoclonal,
pubmed-meshheading:9779699-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:9779699-Antibodies, Neoplasm,
pubmed-meshheading:9779699-Antineoplastic Agents,
pubmed-meshheading:9779699-Drug Administration Schedule,
pubmed-meshheading:9779699-Female,
pubmed-meshheading:9779699-Humans,
pubmed-meshheading:9779699-Infusions, Intravenous,
pubmed-meshheading:9779699-Lymphoma, B-Cell,
pubmed-meshheading:9779699-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9779699-Male,
pubmed-meshheading:9779699-Mycosis Fungoides,
pubmed-meshheading:9779699-Remission Induction
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
|
|
pubmed:affiliation |
Department of Oncology, Karolinska Hospital, Stockholm, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
